Group 1 - The core point of the announcement is the approval of the first vesting period of the 2024 restricted stock incentive plan, allowing 122 eligible participants to receive a total of 210,000 shares [1][2] - The supervisory board confirmed that the vesting conditions for the first part of the restricted stock incentive plan have been met, in accordance with relevant laws and regulations [1][2] - The voting results showed unanimous support from all three supervisors, with 100% in favor and no abstentions or oppositions [2][3] Group 2 - The supervisory board also approved the cancellation of certain previously granted but unvested restricted stocks, which complies with the relevant legal and regulatory requirements [2][3] - The decision to cancel the unvested stocks was deemed not to harm the interests of the company or its shareholders [2]
昊帆生物: 第四届监事会第九次会议决议公告